维普中文期刊产品整合服务
28篇 您的检索式:作者名="Muzykantov VR"
    题名 作者 年代 出处 被引量
1Distribution of type Ⅰ,Ⅲ,Ⅳ and Ⅴ collagen in normal and atherosclerotic human arterial wall:immunomorphological characteristics显示文摘Shekhonin BV Domogatsky SP Muzykantov VR 1985Coll Relat Res1985,5,:1
2Drag delivery by red blood cells: vas- cular carriers designed by mother nature显示文摘Muzykantov VR 2010Expert Opin Drug Deliv2010,7,4:1
3Targeting of superoxide dismutase and catalase to vascular endothelium显示文摘Muzykantov VR 2001J Control Release2001,71,:1
4Antioxidant strategies in respiratory medicine显示文摘Christofidou Solomidou M Muzykantov VR 2006Treat Respir Med2006,5,1:1
5Antioxidant strategies in respiratory medicine显示文摘Christofidou-Solomidou M Muzykantov VR 2006Treat Respir Med2006,5,1:1
6Antioxidant strategies in respiratory medicine 显示文摘Christofidou-Solomidou M Muzykantov VR 2006Treat Respir Med2006,5,1:1
7Antioxidant strategies in respiratory medicine显示文摘Christofidou-Solomidou M Muzykantov VR 2006Treat Respir Med2006,5,1:1
8Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor 显示文摘Zaltzman AB Van den Berg CW Muzykantov VR 1995Biochem J1995,307,3:1
9Targeting of superoxide dismutase and catalase to vascular endothelium显示文摘Muzykantov VR 2001J Control Release2001,71,:1
10Targeting of superoxide dismutue and catalase to vascular endothelium显示文摘Muzykantov VR 2001J Control Release2001,71,1:1
11Tavgeting of superoxide dismutase and catalase to vascular endothelilm显示文摘Muzykantov VR 2001J Control Release2001,71,1:1
12Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence ofneutralization of the complement regulators CD59 anddecay accelerating factor显示文摘Zaltzman AB Van den Berg CW Muzykantov VR 1995Biochem J1995,307,3:1
13Delivery of antioxidant enzyme proteins to the lung显示文摘Muzykantov VR 2001Antioxidants and Redox Signaling2001,3,1:1
14Drug delivery carriers on the fringes: natural red blood cells versus synthetic multilayered capsules 显示文摘Muzykantov VR 2013Expert Opin Drug Deliv2013,10,1:1
15Delivery of antioxidant enzyme proteins to the lung显示文摘 2001Antioxid Redoxsignal2001,3,1:1
16Tavgeting of Superoxide dismutase and catalase to Vascular endothelilm显示文摘Muzykantov VR 2001Control Release2001,71,1:1
17Distribution of type I,III,IV and V col agen in normal and atherosclerotic human arterial wal:immunomorphological characteristics显示文摘Shekhonin BV Domogatsky SP Muzykantov VR 0,,04:1
18Target-sensi- tive immunoerythrocytes:interaction of biotinylated red blood ceils with immobilized avidin induces their |ysis by complement 显示文摘Muzykantov VR Zasltsman AB Sminiov MD 1996Biochim Biophys Acta1996,1279,:1
19Targeting of superoxide dismutase and catalase to vascular endothelium显示文摘Muzykantov VR 0,,:1
20Antioxidant strategies in respiratory medicine显示文摘Christofidou-Solomidou M Muzykantov VR 2006Treat Respir Med2006,5,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费